Muscarinic & Novel Antipsychotics at Psych Congress 2026
2 sessions on muscarinic & novel antipsychotics · September 15–19, 2026, New Orleans, LA. Compare muscarinic & novel antipsychotics at other meetings →
Tuesday, September 15
Course
Advanced Psychopharmacology Intensive: Emerging Neurobiologic Targets and Metabolic Pathways Reshaping Psychiatric Treatment
Brittany Albright · Rakesh Jain · Gregory Mattingly · David Plante
Half-day ticketed intensive built around four expert-led modules on treatment mechanisms moving beyond monoamines: orexin-based agents, glutamate/dopamine circuit approaches, muscarinic receptor modulation, and GLP-1/bioenergetic pathways.
GLP-1 & Metabolic Psychiatry · Neuroscience & Mechanisms · Drug Pipeline & Clinical Trials
Symposium · MasterClass
MasterClass: Presynaptic Possibilities: The Past, Present, and Future of Modulating Dopamine
Christoph U. Correll · Chelsie Monroe
Covers presynaptic dopamine modulation in schizophrenia and bipolar I mania, including evidence for selective muscarinic agents and how to apply them to individual patients.
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5